Protocol Ledger

NCT04411199 · Phase III · COMPLETED

D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

Interventional Phase III clinical trial protocol NCT04411199 sponsored by PolyPid in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-12-15 Enrollment: 975 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04411199
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)975 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04411199
Protocol FieldVerified Registry Value
NCT IdentifierNCT04411199
Consolidated Lead SponsorPolyPid
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment975 participants (ACTUAL)
Registered Start Date2020-12-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04411199
Hospital Research SiteLocationSite Profile
Washington University and Siteman Cancer CenterSaint Louis, MOOpen Hospital Dossier ->
Baylor University Medical CenterDallas, TXOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI